October 09, 2026 06:32 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Bold and inventive’: Canadian poet Anne Carson wins 2026 Nobel Prize in Literature | ‘Attempt to destabilise world’s largest democracy’: 42 retired judges rally behind Gyanesh Kumar over ‘vote chori’ row | ‘Vote chor, gaddi chod’: Dhruv Rathee, Prakash Raj join Bengaluru protest against Gyanesh Kumar | India condemns Houthi attacks on Saudi airports, calls targeting of civilian infrastructure unacceptable | Dalal Street bloodbath: Investors lose Rs. 8 lakh crore as Sensex crashes over 1,000 points | Amazon layoffs hit India, US and UK: Fresh job cuts rock e-commerce giant amid festive shopping season | Bollywood mourns Nana Patekar: Anupam Kher, Akshay Kumar, Jr NTR, Suniel Shetty pay emotional tributes | ‘He was never wavering while expressing his opinions’: PM Modi mourns Nana Patekar | Nana Patekar dies at 75: Veteran actor suffers cardiac arrest at Goa home | RBI shocks borrowers with first repo rate hike since 2023; rates raised to 5.50%
Covid-19 Vaccine
Image Credit: Pixabay

Covid-19 vaccine could be ready by December: Serum Institute's Adar Poonawalla

| @indiablooms | Oct 29, 2020, at 04:38 pm

New Delhi/Pune/IBNS: Giving a hope to 1.3 billion people of India, vaccine manufacturer Serum Institute of India (SII)'s chief Adar Poonawalla has said the Oxford University's Covid-19 vaccine can be made available in the country by December 2020.

In an interview with English news channel NDTV, Poonawalla on Wednesday said, "If we don't go for an emergency license, our trials should be over by December and then we can maybe we can launch in India in January subject to the UK trial also being completed which it's on the verge on being completed."

"If the UK in the next two weeks were to unblind their study and share the data and be confident that it's safe, then we can, after two-three weeks, apply to the Indian regulator to look at a possible emergency license if that's what the government of India wants," he added.

The SII chief further said, "That review could take about two-three weeks I imagine and then you can have a vaccine by December but all these would have to happen and I don't want to venture a guess whether that would happen or not happen because it's not my place to do so - that's for the health ministry officials to decide."

The SII is working on multiple Covid-19 vaccines including the one developed by Oxford University, named Covishield in the Asian country.

At a time France and Germany are getting into the anti-Covid-19 lockdown mode again, the Novel Coronavirus tally in India on Thursday went past the 80-lakh mark with the reporting of 49,881 new infections in the last 24 hours.

As per the latest update by India's Health Ministry, the country has reported 517 deaths apparently due to the infection in the last 24 hours.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.